Pfizer Says Lower Dose of Its COVID Vaccine Protects Younger Children
FRIDAY, Oct. 22, 2021 (HealthDay News) — A lower dose of Pfizer’s coronavirus vaccine is 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11, according to new clinical trial data from the company. The data was given to the U.S. Food and Drug Administration on Friday, andContinue Reading